Möchten Sie immer auf dem neuesten Stand bleiben?

Longeveron will present at BIO 2026. CEO, CFO & BD will host meetings to explore partnership opportunities for its 4 stem cell therapy developmet programs.

Austin, June 04, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, The Molecular Imaging Market was valued at USD 9.25 Billion in 2025 and is expected to reach USD 14.23 Billion by 2035, growing at...

Pharming today announced that the U.S. FDA accepted its sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS

Two regenerative aesthetic and longevity products, with clinically validated ingredients, are expected to reach the U.S. market during 2026.

Immuneering Presents Compelling 17.3-Month Median Overall Survival and Favorable Tolerability with Atebimetinib + Chemotherapy in First-Line Pancreatic Can

IRVINE, Calif., June 01, 2026 (GLOBE NEWSWIRE) -- Lantronix Inc. (Nasdaq: LTRX), a global provider of Edge AI and Industrial IoT solutions powering NDAA-compliant unmanned systems, critical...

Los Angeles, CA , May 30, 2026 (GLOBE NEWSWIRE) -- Pompa Program, a wellness coaching program, has surpassed 1,300 ratings on Trustpilot while holding a 4.7 out of 5-star average — a milestone...

FLORHAM PARK, N.J., May 29, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (the “Company”), a longevity-focused regenerative and cellular medicine company, today announced that it received...

Austin, May 29, 2026 (GLOBE NEWSWIRE) -- The Fleet Management Market is projected to increase at a compound annual growth rate (CAGR) of 13.48% from 2026 to 2035, from its 2025 valuation of USD...

BOSTON, May 29, 2026 (GLOBE NEWSWIRE) -- Imviva Biotech, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced that it will present data...